Deutsche Bank
ATHE

Deutsche Bank’s Alterity Therapeutics ATHE Stock Holding History

Deutsche Bank’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,452
Closed -$49K – 5148
2018
Q3 		$49K Sell
2,452
-220
-8% -$4.58K ﹤0.01% 4707
2018
Q2 		$50K Buy
2,672
+1,930
+260% +$38.3K ﹤0.01% 4780
2018
Q1 		$15K Buy
+742
New +$19.9K ﹤0.01% 5057
2017
Q4 		– Hold
0
– – – 4985
2017
Q3 		– Hold
0
– – – 4865
2017
Q2 		– Hold
0
– – – 4922
2017
Q1 		– Sell
-1,940
Closed -$45.8K – 4898
2016
Q4 		$31K Buy
1,940
+100
+5% +$2.67K ﹤0.01% 4479
2016
Q3 		$83K Buy
+1,840
New +$91.7K ﹤0.01% 4008
2016
Q2 		– Hold
0
– – – 5163
2016
Q1 		– Sell
-7
Closed – – 5138
2015
Q4 		$0 Hold
7
– – ﹤0.01% 5263
2015
Q3 		$0 Hold
7
– – ﹤0.01% 5187
2015
Q2 		$0 Hold
7
– – ﹤0.01% 5322
2015
Q1 		$0 Hold
7
– – ﹤0.01% 5120
2014
Q4 		$0 Sell
7
-67
-91% -$7.24K ﹤0.01% 6135
2014
Q3 		$8K Sell
74
-33
-31% -$4.42K ﹤0.01% 5441
2014
Q2 		$14K Buy
107
+74
+224% +$8.44K ﹤0.01% 5418
2014
Q1 		$5K Hold
33
– – ﹤0.01% 5170
2013
Q4 		$14K Buy
33
+30
+1,000% +$8.98K ﹤0.01% 4822
2013
Q3 		$0 Buy
+3
New +$689 ﹤0.01% 5527

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Deutsche Bank's ATHE Position: Q4 2018 in Review

Deutsche Bank sold out of Alterity Therapeutics (ATHE) in Q4 2018, closing a stake of 2,452 shares — an estimated $49K sold.

Deutsche Bank first reported a position in ATHE in Q3 2013 and held it in 15 quarters. The position peaked at $83K in Q3 2016. 11 funds tracked by Wall St. Rank hold ATHE as of Q4 2018.

  • Deutsche Bank reported no remaining Alterity Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 2,452 Alterity Therapeutics shares in Q4 2018, an estimated $49K.
  • Deutsche Bank first reported a position in Alterity Therapeutics in Q3 2013 and held it in 15 quarters.
  • Deutsche Bank's Alterity Therapeutics position peaked at $83K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.